The chief financial officer (CFO) at Belluscura, Simon Neicheril, has resigned from the company.

He will leave the board and the group from 2 May to take up a new position.

The UK-founded, US-based medical device company said that its chairman, Paul Tuson, will take board responsibility for finance.

He qualified as a chartered accountant at KPMG and brings over 30 years’ post-qualification experience to the role. He has also served as CFO at a number of AIM-listed companies.

The announcement comes after the firm’s sales increased by almost 450% year-on-year to $912,000 in the first quarter of its financial year.

Tuson said: "Simon joined Belluscura in October 2023. The board greatly appreciates his hard work, professionalism and dedication. We wish him every success in the future.

"Trading in the period since completing share placing in February has been satisfactory. The prospects for Q2 FY2025 are encouraging, despite the uncertainties surrounding the recent imposition of US tariffs.

"The company continues to monitor the seemingly fluid position of US tariffs and is actively seeking to minimise adverse implications to the company and the users of its portable oxygen container products based in the USA."

---